Handbook of HER2-Targeted Agents in Breast Cancer

Mostrar otras versiones (1)

This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targete...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores principales: Alvarez, Ricardo H. (Autor), Cortés, Javier (Autor), Falzon, Mary (Autor), Gandy, Michael (Autor), Gianni, Luca (Autor), Harbeck, Nadia (Autor), Piccart, Martine (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cham : Springer International Publishing : Imprint: Adis, 2016.
Edición:2nd ed. 2016.
Temas:
Oncology.
Primary care (Medicine).
Radiology.
Primary Care Medicine.
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-319-28216-9
003 DE-He213
005 20220120041321.0
007 cr nn 008mamaa
008 160514s2016 sz | s |||| 0|eng d
020 |a 9783319282169  |9 978-3-319-28216-9 
024 7 |a 10.1007/978-3-319-28216-9  |2 doi 
050 4 |a RC254-282 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 616.994  |2 23 
100 1 |a Alvarez, Ricardo H.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Handbook of HER2-Targeted Agents in Breast Cancer  |h [electronic resource] /  |c by Ricardo H Alvarez, Javier Cortés, Mary Falzon, Michael Gandy, Luca Gianni, Nadia Harbeck, Martine Piccart. 
250 |a 2nd ed. 2016. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Adis,  |c 2016. 
300 |a XI, 110 p. 17 illus., 16 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Introduction and background biology -- HER2 testing -- HER2-positive breast cancer: neoadjuvant and adjuvant therapy -- HER2-positive metastatic breast cancer: first-line treatment -- HER2-positive metastatic breast cancer: second-line treatment -- Emerging targeted agents for HER2-positive breast cancer. 
520 |a This concise handbook provides oncologists and other healthcare providers with crucial updates in the field, including an updated review of the current understanding of the biology of the HER2 pathway, an overview of HER2-testing, and evidence-based discussions of available and emerging HER2-targeted treatment options. An essential clinical text for physicians that screen and treat patients with breast cancer and require an accessible, up-to-date survey of the dynamic treatment landscape. 
650 0 |a Oncology. 
650 0 |a Primary care (Medicine). 
650 0 |a Radiology. 
650 1 4 |a Oncology. 
650 2 4 |a Primary Care Medicine. 
650 2 4 |a Radiology. 
700 1 |a Cortés, Javier.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
700 1 |a Falzon, Mary.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
700 1 |a Gandy, Michael.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
700 1 |a Gianni, Luca.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
700 1 |a Harbeck, Nadia.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
700 1 |a Piccart, Martine.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783319282145 
776 0 8 |i Printed edition:  |z 9783319282152 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-319-28216-9  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714) 

Ejemplares similares